# Metabolomic Analysis of the Effects of Phenylbutyrate (PB) in Patients with Mya

Canonical: https://abierto.us/opportunities/75n98026q01076

- Solicitation number: 75N98026Q01076
- Notice type: Special notice
- Status: Closed. Deadline was September 8, 2026 at 10:00 AM EDT
- Department: Department of Health and Human Services
- Agency: National Institutes of Health
- Contracting office: National Institutes of Health Nhlbi (75N920)
- NAICS: 621511 Medical Laboratories
- Product or service code: Q301 Reference Laboratory Testing
- First posted: September 1, 2026
- Last posted: September 1, 2026
- SAM.gov: https://sam.gov/workspace/contract/opp/9ee1f6489fb54812995fab501741b3f3/view

## Description

Metabolomic Analysis of the Effects of Phenylbutyrate (PB) in Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)

## Publications

- September 1, 2026: Special notice, due September 8, 2026 at 10:00 AM EDT. Notice 9ee1f6489fb54812995fab501741b3f3. https://sam.gov/workspace/contract/opp/9ee1f6489fb54812995fab501741b3f3/view

## Points of contact

- KNOX, TARA C, tara.knox@nih.gov, +1 000 000 0000

---
Source: SAM.gov Contract Opportunities bulk extract. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/75n98026q01076.